Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 15, 2017

Primary Completion Date

May 4, 2017

Study Completion Date

May 31, 2018

Conditions
Peripheral Arterial DiseaseIntermittent Claudication
Interventions
DEVICE

Bard® LifeStent® 5F Vascular Stent System

The LifeStent® Vascular Stent is a peripheral stent intended to improve luminal diameter in the treatment of symptomatic de-novo or restenotic lesions up to 240 mm in length in the native superficial femoral artery (SFA) and popliteal artery with reference vessel diameters ranging from 4.0 - 6.5 mm.

Trial Locations (4)

13347

Gemeinschaftspraxis fuer Radiologie, Berlin

67657

Praxis fuer Interventionelle Angiologie, Kaiserslautern

76646

Fuerst-Stirum-Klinik Bruchsal, Bruchsal

79189

Universitaets-Herzzentrum Freiburg, Klinik fuer Kardiologie und Angiologie II, Bad Krozingen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

C. R. Bard

INDUSTRY

NCT03071146 - Utility, Safety, and Effectiveness of the Bard LifeStent 5F Vascular Stent System | Biotech Hunter | Biotech Hunter